Layth Mula-Hussain Highlights Prevalence of Molecular Mutations in NSCLC
Layth Mula-Hussain, Radiation Oncologist at BC Cancer, shared a post on LinkedIn about a paper by AbdulAziz AlJassim et al. published on Journal of Immunotherapy and Precision Oncology:
“Happy to be part of this research work:
Prevalence of Molecular Mutations in Non–Small Cell Lung Cancer and Current Treatment Approaches in the MENA Region: Systematic Review and Expert Opinion.”
Title: Prevalence of Molecular Mutations in Non–Small Cell Lung Cancer and Current Treatment Approaches in the MENA Region: Systematic Review and Expert Opinion
Authors: AbdulAziz AlJassim, Aladdin Kanbour, Fathi Azribi, Muath AlNassar, Riadh Mohsen, Sahar Dawod, Selvaraj Giri, Michael Nasr Kamal, Ali AlJabban, Layth Mula-Hussain, Bader Alshamsan, Emad Anwar
Read the full article.
More posts featuring Layth Mula-Hussain on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023